Molecular Mechanisms of Polybrominated Diphenyl Ethers (BDE-47, BDE-100, and BDE-153) in Human Breast Cancer Cells and Patient-Derived XenograftsTOXICOLOGICAL SCIENCESIF4.12019-02-2333OAAI
Use of dual mTOR inhibitor MLN0128 against everolimus-resistant breast cancerBREAST CANCER RESEARCH AND TREATMENTIF32018-04-0517OAAI
mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph+ and Ph-like B-ALLmTORC1抑制在Ph和Ph样b-all中诱导对甲氨蝶呤和6-巯基嘌呤的抗性MOLECULAR CANCER THERAPEUTICSIF5.52017-09-0414OAAI
Identification of molecular pathways to define the intake rate of patient derived hormone receptor positive (HR plus ) breast cancer xenografts (PDXs) in NOD/SCID/interleukin-2 receptor gamma chain null (NSG) miceCANCER RESEARCHIF16.62016-02-150PRE
Inhibition of mTOR induces chemoresistance in B-cell acute lymphoblastic leukemiaMOLECULAR CANCER THERAPEUTICSIF5.52015-07-060OA
AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimensBREAST CANCER RESEARCH AND TREATMENTIF32015-05-1210OAAI
Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycinBREAST CANCER RESEARCH AND TREATMENTIF32015-04-2361OAAI
Inhibition of mTOR induces multidrug resistance in B-progenitor acute lymphocytic leukemiaCANCER RESEARCHIF16.62014-10-091PRE
Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatinMOLECULAR CANCER THERAPEUTICSIF5.52006-12-1539PREAI
Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascadeAPOPTOSISIF8.12006-11-2137PREAI